Dallas cancer drug maker Gradalis, which is run by the former president of the Mary Crowley Cancer Research Centers, has raised nearly $44 million.
Form D Friday: Dallas biotech firm raises $44M to fight ovarian cancer
Dallas cancer drug maker Gradalis, which is run by the former president of the Mary Crowley Cancer Research Centers, has raised nearly $44 million.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.